Blake Borgeson insider trades: Recursion Pharmaceuticals (RXRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Blake reports to the SEC
Open-market buys and sales
67 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | RXRX | ↓ Sell | 40,000 | $3.88 | $155K | Direct | Nov 4, 2026 (1d) |
| Oct 6, 2026 | RXRX | ↓ Sell | 50,000 | $4.84 | $242K | Direct | Oct 7, 2026 (1d) |
| Sep 1, 2026 | RXRX | ↓ Sell | 30,000 | $3.34 | $100K | Direct | Sep 2, 2026 (1d) |
| Jul 7, 2026 | RXRX | ↓ Sell | 40,000 | $3.96 | $159K | Direct | Jul 9, 2026 (2d) |
| Jun 2, 2026 | RXRX | ↓ Sell | 30,000 | $3.68 | $110K | Direct | Jun 4, 2026 (2d) |
| May 5, 2026 | RXRX | ↓ Sell | 30,000 | $3.52 | $106K | Direct | May 7, 2026 (2d) |
| Apr 7, 2026 | RXRX | ↓ Sell | 30,000 | $3.10 | $93K | Direct | Apr 8, 2026 (1d) |
| Mar 3, 2026 | RXRX | ↓ Sell | 170,000 | $3.46 | $588K | Direct | Mar 4, 2026 (1d) |
| Feb 3, 2026 | RXRX | ↓ Sell | 220,000 | $4.20 | $924K | Direct | Feb 6, 2026 (3d) |
| Jan 6, 2026 | RXRX | ↓ Sell | 220,000 | $4.36 | $959K | Direct | Jan 8, 2026 (2d) |
| Dec 2, 2025 | RXRX | ↓ Sell | 220,000 | $4.37 | $961K | Direct | Dec 4, 2025 (2d) |
| Nov 12, 2024 | RXRX | ↓ Sell | 11,447 | $7.64 | $87K | Direct | Nov 14, 2024 (2d) |
| Oct 29, 2024 | RXRX | ↓ Sell | 11,447 | $6.72 | $77K | Direct | Oct 31, 2024 (2d) |
| Oct 15, 2024 | RXRX | ↓ Sell | 11,447 | $6.67 | $76K | Direct | Oct 17, 2024 (2d) |
| Oct 1, 2024 | RXRX | ↓ Sell | 11,447 | $6.22 | $71K | Direct | Oct 3, 2024 (2d) |
| Sep 17, 2024 | RXRX | ↓ Sell | 11,447 | $6.84 | $78K | Direct | Sep 19, 2024 (2d) |
| Sep 3, 2024 | RXRX | ↓ Sell | 11,447 | $6.27 | $72K | Direct | Sep 5, 2024 (2d) |
| Aug 20, 2024 | RXRX | ↓ Sell | 11,447 | $7.12 | $82K | Direct | Aug 22, 2024 (2d) |
| Aug 6, 2024 | RXRX | ↓ Sell | 11,447 | $6.82 | $78K | Direct | Aug 8, 2024 (2d) |
| Jul 23, 2024 | RXRX | ↓ Sell | 11,447 | $8.48 | $97K | Direct | Jul 25, 2024 (2d) |
| Jul 9, 2024 | RXRX | ↓ Sell | 11,447 | $7.32 | $84K | Direct | Jul 11, 2024 (2d) |
| Jun 25, 2024 | RXRX | ↓ Sell | 11,447 | $9.51 | $109K | Direct | Jun 27, 2024 (2d) |
| Jun 11, 2024 | RXRX | ↓ Sell | 11,447 | $8.45 | $97K | Direct | Jun 13, 2024 (2d) |
| May 28, 2024 | RXRX | ↓ Sell | 11,447 | $9.17 | $105K | Direct | May 30, 2024 (2d) |
| May 14, 2024 | RXRX | ↓ Sell | 20,054 | $10.12 | $203K | Direct | May 16, 2024 (2d) |
| Apr 30, 2024 | RXRX | ↓ Sell | 11,447 | $7.95 | $91K | Direct | May 2, 2024 (2d) |
| Apr 16, 2024 | RXRX | ↓ Sell | 11,447 | $7.66 | $88K | Direct | Apr 18, 2024 (2d) |
| Apr 2, 2024 | RXRX | ↓ Sell | 11,447 | $8.82 | $101K | Direct | Apr 3, 2024 (1d) |
| Mar 19, 2024 | RXRX | ↓ Sell | 20,054 | $10.79 | $216K | Direct | Mar 21, 2024 (2d) |
| Mar 5, 2024 | RXRX | ↓ Sell | 20,054 | $12.06 | $242K | Direct | Mar 7, 2024 (2d) |
| Feb 20, 2024 | RXRX | ↓ Sell | 20,054 | $12.32 | $247K | Direct | Feb 21, 2024 (1d) |
| Feb 6, 2024 | RXRX | ↓ Sell | 11,447 | $9.30 | $106K | Direct | Feb 8, 2024 (2d) |
| Jan 23, 2024 | RXRX | ↓ Sell | 20,054 | $10.58 | $212K | Direct | Jan 25, 2024 (2d) |
| Jan 9, 2024 | RXRX | ↓ Sell | 20,054 | $13.62 | $273K | Direct | Jan 11, 2024 (2d) |
| Dec 26, 2023 | RXRX | ↓ Sell | 20,054 | $10.63 | $213K | Direct | Dec 28, 2023 (2d) |
| Dec 12, 2023 | RXRX | ↓ Sell | 11,447 | $7.40 | $85K | Direct | Dec 14, 2023 (2d) |
| Nov 28, 2023 | RXRX | ↓ Sell | 11,447 | $6.72 | $77K | Direct | Nov 30, 2023 (2d) |
| Nov 14, 2023 | RXRX | ↓ Sell | 8,885 | $6.32 | $56K | Direct | Nov 16, 2023 (2d) |
| Oct 31, 2023 | RXRX | ↓ Sell | 8,885 | $5.27 | $47K | Direct | Nov 2, 2023 (2d) |
| Oct 17, 2023 | RXRX | ↓ Sell | 8,885 | $6.58 | $58K | Direct | Oct 19, 2023 (2d) |
| Oct 3, 2023 | RXRX | ↓ Sell | 8,885 | $7.29 | $65K | Direct | Oct 5, 2023 (2d) |
| Sep 19, 2023 | RXRX | ↓ Sell | 8,885 | $8.36 | $74K | Direct | Sep 21, 2023 (2d) |
| Sep 5, 2023 | RXRX | ↓ Sell | 8,885 | $8.79 | $78K | Direct | Sep 7, 2023 (2d) |
| Aug 22, 2023 | RXRX | ↓ Sell | 8,885 | $8.91 | $79K | Direct | Aug 24, 2023 (2d) |
| Aug 8, 2023 | RXRX | ↓ Sell | 17,770 | $11.16 | $198K | Direct | Aug 10, 2023 (2d) |
| Jul 25, 2023 | RXRX | ↓ Sell | 18,719 | $14.61 | $273K | Direct | Jul 27, 2023 (2d) |
| Jul 11, 2023 | RXRX | ↓ Sell | 8,885 | $6.89 | $61K | Direct | Jul 13, 2023 (2d) |
| Jun 27, 2023 | RXRX | ↓ Sell | 8,885 | $7.39 | $66K | Direct | Jun 29, 2023 (2d) |
| Jun 13, 2023 | RXRX | ↓ Sell | 15,485 | $9.98 | $155K | Direct | Jun 15, 2023 (2d) |
| May 30, 2023 | RXRX | ↓ Sell | 8,885 | $8.79 | $78K | Direct | Jun 1, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RXRX insiders
Open-market trades in the last 12 months
About Blake Borgeson's insider trades
Blake Borgeson is a director at Recursion Pharmaceuticals (RXRX). Since Nov 18, 2021, Blake has reported no open-market purchases and 67 sales worth $10.7M on SEC Form 4. In the last 12 months: 11 sales ($4.4M).
Their filings also include grants and awards (16 filings), gifts (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RXRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.